Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications.
Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line